HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.76 HKD | -2.72% |
|
-0.13% | 0.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hansoh Pharmaceutical Group Company Limited specializes in the development, manufacture and marketing of pharmaceutical products for the treatment of tumor, infectious, metabolic and autoimmune diseases. Net sales break down by revenue source as follows:
- sales of pharmaceutical products (99.1%);
- sales of research and development services (0.9%).
Sector
Pharmaceuticals
Calendar
2024-08-28
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
14.98
CNY
Average target price
17.47
CNY
Spread / Average Target
+16.60%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 12.25B | |
| +28.10% | 676B | |
| +24.27% | 559B | |
| -7.84% | 356B | |
| +14.71% | 320B | |
| +4.88% | 286B | |
| +2.62% | 213B | |
| +0.15% | 207B | |
| -9.41% | 199B | |
| -7.77% | 142B |
- Stock Market
- Equities
- 3692 Stock
- News Hansoh Pharmaceutical Group Company Limited
- Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$20.31 From HK$20.88, Keeps at Buy
